Navigation Links
Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice,with Transplant of Purified Donor Blood Stem Cells

SAN CARLOS, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Cellerant Therapeutics today announced the publication of data suggesting that established autoimmune disease can be reversed or stabilized by the transplantation of purified allogeneic (donated) hematopoietic (blood forming) stem cells (HSC) in a mouse study of Systemic Lupus Erythematosus (SLE). Subjects that underwent this procedure exhibited improved overall survival and decreased lupus symptoms. The research, led by Dr. Julie Christensen with colleagues from Cellerant and Stanford University, was published on April 13, 2007 as a First Edition Paper in the online version of the American Society of Hematology's journal, BLOOD (Smith-Berdan et. al., DOI 10.1182/BLOOD-2007-03-081497).

"The demonstration of successful reversal of the disease using purified stem cells with non-myeloablative conditioning offers a novel strategy to treat autoimmune diseases such as lupus with decreased morbidity," said Ramkumar Mandalam, Ph.D., Vice President of Pharmaceutical Operations. "This study also provides further support for our belief that purified stem cells may make it possible to use un-matched donors, such as a parent or non-identical sibling, for a variety of HSC treatment procedures."

"The publication of this preclinical data further validate Cellerant's unique use of pure hematopoietic stem cells for a wide range of therapeutic applications, including lupus and other autoimmune disorders, as well as for cancer and blood disorders," commented Bruce Cohen, Cellerant's President and CEO. "This finding is consistent with recent reports on successful use of hematopoietic stem cell transplantation for the treatment of autoimmune diseases and merits evaluation of pure stem cells in treating such diseases."

Cellerant researchers worked with specialized mice that are prone to an autoimmune condition that closely resembles human SLE. The study evaluated both
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:7/11/2014)... 11, 2014 According to ... Composition of Material, Application (Healthcare, Homeland security, Industrial ... (Personal Instrument, Hand-Held Instruments, Fixed, and Installed Instruments) ... 2013 - 2020", published by MarketsandMarkets, the Scintillator Market is ... from 2014 to 2020, and reach $479.16 Million ...
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
(Date:7/10/2014)...  Major advances in radiation therapy and radiosurgery ... in a three-day Oncology Summit taking place in ...  Renowned national and international cancer experts from seven countries ... knowledge on modern technologies making treatment for cancer ... The Summit will address a wide spectrum ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... /PRNewswire-Asia/ -- To thank customers for their continuous support ... , heart beat watches, blood pressure monitors and so ... to offer these products with discounts ranging ... and offer more suitable products to customers, Wuzhou Changlian ...
... Calif., and CAMBRIDGE, Mass., June 8, 2011 ... discovery and development of innovative medicines targeting microRNAs, and ... leading RNAi therapeutics company, today announced the publication ... in mice about the antagonism of microRNA-103 and microRNA-107 ...
Cached Medicine Technology:Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 2Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 3Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 4Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 5Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 6Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 7
(Date:7/12/2014)... Los Angeles, CA (PRWEB) July 12, 2014 ... a buyer power score of 4.1 out of ... the market that have been underpinning buyer negotiation ... to IBISWorld procurement analyst Anna Son, “during the ... along with rising costs associated with new product ...
(Date:7/12/2014)... Ladies, it doesn't matter what your budget is, the ... for an affordable gown can visit Discount-Dress.com (a ... their dream items. Recently, the company has announced its new ... with that, it is also providing great discounts for these ... deadline of this promotion is July 29, 2014. , ...
(Date:7/11/2014)... The American Association of Poison Control ... are commending Senator Bill Nelson (D-FL) for his introduction ... on July 10, 2014. Along with fellow Senate co-sponsors, ... (CPSC) to enact rules requiring safer, child-resistant packaging for ... Senate co-sponsors of the bill include: Sen. Richard Blumenthal ...
(Date:7/11/2014)... 11, 2014 As transvaginal mesh ... Johnson & Johnson’s Ethicon Inc. unit continue to ... that the Texas Attorney General’s Office has acknowledged ... surgical mesh products used to treat pelvic organ ... report from kens5.com, the probe began nearly two ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- People with the lowest ... called peripheral artery disease (PAD), a new study suggests. ... blood to the limbs, most often the legs. The condition ... of the arteries throughout the body. People with PAD have ... analyzed data from nearly 6,800 people with PAD who took ...
Breaking Medicine News(10 mins):Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Poor More Prone to Leg Circulation Trouble 2
... of cancer and the economy are converging in the Texas ... on funding for the Cancer Prevention and Research Institute of ... authorizing $3 billion over 10 years in general obligation bonds ... come for the Legislature to fulfill the wishes of Texas ...
... of $0.51(1), Excluding $0.02 of Expenses Related to Tepnel ... a Constant Currency(2) Basis ---- Company Generates Total Revenues ... Million --SAN DIEGO, April 30 Gen-Probe Incorporated (Nasdaq: ... the first quarter of 2009, including non-GAAP earnings per ...
... Gives Schools a Free ,Simple as ABC, Always Be ... Calif., April 30 Woodward Laboratories, a leading antimicrobial ... alcohol-free instant hand sanitizer that exceeds the Food and ... washes, reports a tremendous spike in sales in the ...
... group of arthritidies that share clinical features ... at sites where tendons attach to bone. ... inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and ... Chlamydia pneumoniae (which are often asymptomatic) frequently ...
... April 30 The Missouri House today amended ... funds to go to grants for maternity homes and pregnancy ... being considered by the Missouri Senate. , , ... homes and pregnancy resource centers are essential to helping pregnant ...
... Contract Manufacturing Organizations Now Available on goBalto.comSAN FRANCISCO, ... partnering site for the pharmaceutical development and drug ... LLC is making its proprietary list ... and Contract Manufacturing Organizations (CMOs) available on ...
Cached Medicine News:Health News:Texas Cancer Organizations Urge State Legislature to Fully Fund the Cancer Prevention and Research Institute of Texas 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 3Health News:Gen-Probe Reports Financial Results for First Quarter 2009 4Health News:Gen-Probe Reports Financial Results for First Quarter 2009 5Health News:Gen-Probe Reports Financial Results for First Quarter 2009 6Health News:Gen-Probe Reports Financial Results for First Quarter 2009 7Health News:Gen-Probe Reports Financial Results for First Quarter 2009 8Health News:Gen-Probe Reports Financial Results for First Quarter 2009 9Health News:Gen-Probe Reports Financial Results for First Quarter 2009 10Health News:Gen-Probe Reports Financial Results for First Quarter 2009 11Health News:Gen-Probe Reports Financial Results for First Quarter 2009 12Health News:Gen-Probe Reports Financial Results for First Quarter 2009 13Health News:Gen-Probe Reports Financial Results for First Quarter 2009 14Health News:Gen-Probe Reports Financial Results for First Quarter 2009 15Health News:Gen-Probe Reports Financial Results for First Quarter 2009 16Health News:Gen-Probe Reports Financial Results for First Quarter 2009 17Health News:Gen-Probe Reports Financial Results for First Quarter 2009 18Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 2Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 3Health News:Chlamydia may play role in a type of arthritis 2Health News:goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations 2Health News:goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations 3
... The Natural Knee design includes ... proprietary CSTi porous coating option ... patients, a unique bone preserving ... trochlear groove to maximize range ...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... Duracon tibial inserts have radiused A/P ... 4-axis machining, maximizing conformity of the ... of the femoral component. The resulting ... Duracon system, and accommodates the knee's ...
Medicine Products: